医学
癌症登记处
阶段(地层学)
优势比
逻辑回归
癌症
人口
婚姻状况
不利影响
疾病
人口学
内科学
环境卫生
古生物学
生物
社会学
作者
Joan L. Warren,Angela B. Mariotto,Jennifer L. Stevens,Amy J. Davidoff,Veena Shankaran,Kevin C. Ward,Xiao‐Cheng Wu,Stephen M. Schwartz,Lynne Penberthy,K. Robin Yabroff
摘要
PURPOSE This study assessed the prevalence of specific major adverse financial events (AFEs)—bankruptcies, liens, and evictions—before a cancer diagnosis and their association with later-stage cancer at diagnosis. METHODS Patients age 20-69 years diagnosed with cancer during 2014-2015 were identified from the Seattle, Louisiana, and Georgia SEER population–based cancer registries. Registry data were linked with LexisNexis consumer data to identify patients with a history of court-documented AFEs before cancer diagnosis. The association of AFEs and later-stage cancer diagnoses (stages III/IV) was assessed using separate sex-specific multivariable logistic regression. RESULTS Among 101,649 patients with cancer linked to LexisNexis data, 36,791 (36.2%) had a major AFE reported before diagnosis. The mean and median timing of the AFE closest to diagnosis were 93 and 77 months, respectively. AFEs were most common among non-Hispanic Black, unmarried, and low-income patients. Individuals with previous AFEs were more likely to be diagnosed with later-stage cancer than individuals with no AFE (males—odds ratio [OR], 1.09 [95% CI, 1.03 to 1.14]; P < .001; females—OR, 1.18 [95% CI, 1.13 to 1.24]; P < .0001) after adjusting for age, race, marital status, income, registry, and cancer type. Associations between AFEs prediagnosis and later-stage disease did not vary by AFE timing. CONCLUSION One third of newly diagnosed patients with cancer had a major AFE before their diagnosis. Patients with AFEs were more likely to have later-stage diagnosis, even accounting for traditional measures of socioeconomic status that influence the stage at diagnosis. The prevalence of prediagnosis AFEs underscores financial vulnerability of patients with cancer before their diagnosis, before any subsequent financial burden associated with cancer treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI